PRESS RELEASE published on 10/27/2025 at 14:35, 9 months ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc., discloses a 1.81% ownership in Alphawave IP Group plc through Form 8.3 filing. Also making disclosures related to Qualcomm Incorporated Form 8.3 Disclosure Vanguard Group Qualcomm Alphawave IP Group Plc
PRESS RELEASE published on 10/27/2025 at 14:34, 9 months ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% interest in Avadel Pharmaceuticals plc with 5,524,858 ordinary shares. Disclosure made on 24 October 2025 Irish Takeover Panel Vanguard Group Shareholding Interest Disclosure Avadel Pharmaceuticals
BRIEF published on 10/24/2025 at 16:00, 9 months 3 days ago The Vanguard Group Discloses Position in NCC Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group NCC Group
BRIEF published on 10/24/2025 at 15:58, 9 months 3 days ago The Vanguard Group Discloses Stake in Mural Oncology Ordinary Shares The Vanguard Group Stake Disclosure Mural Oncology Takeover Rules
BRIEF published on 10/24/2025 at 15:57, 9 months 3 days ago The Vanguard Group Discloses Position in JTC plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group JTC Plc
PRESS RELEASE published on 10/24/2025 at 15:55, 9 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.89% stake in NCC Group plc as of 23 October 2025. Details in compliance with Rule 8.3 of the Takeover Code Takeover Code Vanguard Group Financial Disclosure Stake Disclosure NCC Group Plc
BRIEF published on 10/24/2025 at 15:55, 9 months 3 days ago The Vanguard Group Discloses Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group Plc
BRIEF published on 10/24/2025 at 15:53, 9 months 3 days ago The Vanguard Group Discloses Position in Spire Healthcare Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare
PRESS RELEASE published on 10/24/2025 at 15:53, 9 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% stake in Mural Oncology plc as per Form 8.3 with relevant securities details Form 8.3 Relevant Securities The Vanguard Group Stake Disclosure Mural Oncology Plc
BRIEF published on 10/24/2025 at 15:52, 9 months 3 days ago The Vanguard Group Discloses Position in Big Yellow Group plc Securities Form 8.3 Disclosure Vanguard Big Yellow
Published on 07/28/2026 at 03:05, 1 hour 41 minutes ago Mining Exploration Entity or Oil And Gas Exploration Entity Quarterly Cash Flow Report
Published on 07/28/2026 at 03:00, 1 hour 46 minutes ago Storm Announces Closing of Oversubscribed $2.95M Private Placement
Published on 07/27/2026 at 14:00, 14 hours 46 minutes ago Silver Storm Announces First Concentrate Shipment from La Parrilla
Published on 07/27/2026 at 13:30, 15 hours 16 minutes ago International Battery Metals Announces CEO Transition
Published on 07/27/2026 at 23:05, 5 hours 41 minutes ago Quantinuum to Report Second Quarter Financial Results on August 11, 2026
Published on 07/27/2026 at 22:45, 6 hours 1 minute ago EQS-Adhoc: Hypoport SE: Gross profit growth and significant increase in EBIT in H1/26
Published on 07/27/2026 at 21:15, 7 hours 31 minutes ago Xryma Plc announces the upcoming launch of XrymaCoin (XREUR), the regulated euro stablecoin designed to work like money
Published on 07/27/2026 at 20:50, 7 hours 56 minutes ago Pentixapharm Completes Capital Increase – New Shares Placed in Full
Published on 07/27/2026 at 20:40, 8 hours 6 minutes ago EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
Published on 07/27/2026 at 18:00, 10 hours 46 minutes ago Saint-Gobain accelerates in Asia with two targeted acquisitions
Published on 07/27/2026 at 08:29, 20 hours 17 minutes ago FREY H1 2026: a platform geared towards a new phase of growth
